Researchers estimate that breast cancer surpassed lung cancer as the most commonly diagnosed cancer globally in 2020, and a study provides insight into financial toxicity's impact on quality of life.

by Bradley Jones

The San Antonio Breast Cancer Symposium and American Society of Hematology meeting go virtual, and COVID-19 brings silver linings to cancer clinical trials.

by Marci A. Landsmann

Many people who pursue low-dose CT lung cancer screening do not follow the recommended screening schedule, and U.K. scientists say the COVID-19 pandemic has set back progress in cancer research.

by Kevin McLaughlin

Researchers investigate why some patients respond exceptionally well to cancer treatment, and the Food and Drug Administration approves a second immunotherapy drug for some breast cancer patients.

by Kate Yandell

A survey indicates that the pandemic is reducing cancer patients' willingness to enroll in cancer clinical trials, and a study find that indoor tanning increases risk of developing melanoma multiple times.

by Kate Yandell

Cancer survivors who use the internet for health-related reasons are more likely to be dissatisfied with their care, and liquid biopsy could misidentify which prostate cancer patients could benefit from targeted therapy.

by Kate Yandell

The U.S. Preventive Services Task Force releases draft guidance suggesting lowering the age at which people should begin routine colorectal cancer screening, and an ovarian cancer patient considers what clinical trials owe participants.

by Kate Yandell

A newly discovered set of salivary glands could have implications for protecting head and neck cancer patients from radiation side effects, and younger melanoma patients respond better to a targeted therapy than older patients.

by Kate Yandell

A study finds that some commercially insured patients getting screening colonoscopies receive a bill for out-of-network services, and a machine learning algorithm helps nudge oncology clinicians to talk about prognosis and the end of life.

by Kate Yandell

A study finds that more than half of cancer patients participate in clinical trials when asked, and an annual survey sheds light on cancer patients' experience of the coronavirus pandemic.

by Kate Yandell